Ancilia Therapeutics
United States
unknown
unknown
Stage
1
Investors
About
Ancilia Therapeutics develops a computational therapeutic platform focused on microbiome-related diseases, applying computational methods to discover or design microbiome-targeted therapies.
Explore Ancilia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.